Code Blue Leader

Medicina

Solo per iPhone

Gratis · Acquisti in‑app · Progettata per iPhone

iPhone

Leading a cardiac arrest (or “Code Blue”) requires a healthcare provider to keep track of many things such as medication doses, timing, interventions, and much more. While their brain is already overloaded, they must make life-altering decisions without any time to think. This is often a very daunting process for new and even experienced healthcare providers. The Code Blue Leader app won’t get nervous or distracted. Code Blue Leader won’t miss a step. Follow evidence-based, real-time, and situation-specific resuscitation guidance. Let Code Blue Leader coordinate and keep track of all the critical parts of a resuscitation so you can think more clearly and more calmly. The Code Blue Leader app acts as a real-time "walk-through" of the ACLS cardiac arrest algorithm. It provides step-by-step guidance based on the input received from the user. Therefore, in order for the app to function as intended, the user must press the appropriate button(s) at each step to ensure the correct algorithm is being followed. Pre-set timers will automatically start/reset based on which buttons are pressed. An integrated metronome maintains the quality and consistency of chest compressions. Timing for CPR and common ACLS medications are included with visual and audible reminders to help cognitively offload these tasks. Furthermore, an automated logging function allows each step of a resuscitation to be accurately recorded. The logs can be copied to the clipboard for documentation purposes. Any medications, interventions, and doses that are prompted by the Code Blue Leader application reflect those recommended by the most up-to-date American Heart Association (AHA) ACLS guidelines. Are you already a Code Blue expert?? Try "Experienced Provider Mode" which removes the dialogue cues and provides a more simplistic "checklist" version for each step of the algorithm. This was created for experienced ACLS healthcare providers who do not wish to follow dialogue prompts and prefer simple reminders.

  • L’app non ha ricevuto un numero sufficiente di valutazioni o recensioni per poter mostrare una panoramica.

Updates to anaphylaxis algorithm. Public availability coming soon! Branding and icon updates. Minor bug fixes and quality of life improvements.

Lo sviluppatore, First Pass Innovation, ha indicato che le procedure per la tutela della privacy dell’app potrebbero includere il trattamento dei dati descritto di seguito. Per scoprire di più, consulta l’informativa sulla privacy dello sviluppatore .

  • Dati collegati a te

    I seguenti dati possono essere raccolti e collegati alla tua identità:

    • Informazioni di contatto
    • Identificativi
  • Dati non collegati a te

    I seguenti dati possono essere raccolti ma non vengono collegati alla tua identità:

    • Dati sull’utilizzo
    • Diagnosi

Le procedure per la tutela della privacy potrebbero variare, ad esempio in base alle funzionalità che utilizzi o alla tua età. Scopri di più

Lo sviluppatore non ha ancora indicato le funzioni di accessibilità supportate dall’app. Scopri di più

  • Dimensioni
    • 34 MB
  • Categoria
    • Medicina
  • Compatibilità
    Richiede iOS 15.1 o versioni successive.
    • iPhone
      Richiede iOS 15.1 o versioni successive.
    • iPod touch
      Richiede iOS 15.1 o versioni successive.
    • Mac
      Richiede macOS 12.0 o versioni successive e un Mac con chip Apple M1 o versioni successive.
    • Apple Vision
      Richiede visionOS 1.0 o versioni successive.
  • Lingue
    • Inglese
  • Età
    13+
  • Acquisti in-app
    • ACLS Monthly Subscription 3,99 €
    • ACLS Yearly Subscription 39,99 €
  • Fornitore
    First Pass Innovation Inc.
    • First Pass Innovation Inc. si identificata come operatore commerciale per questa app e ha confermato che il prodotto o il servizio è conforme alla legge dell’Unione europea.
    • Numero DUNS
      240336320
    • Indirizzo
      3542 Blanshard St
      Unit 206
      Victoria British Columbia V8X 1W3
      Canada
    • Numero di telefono
      +1 2508869657
    • Email
      firstpassinnovation@gmail.com
  • Copyright
    • © 2025 First Pass Innovation Inc.